Skip to main content

Table 1 Clinical and genetic characteristics of colon cancer patients and tumors

From: Prognostic relevance of an epigenetic biomarker panel in sentinel lymph nodes from colon cancer patients

 

Number of patients (n = 201)

Percentage (%)

Stage

 I

38

19

 II

101

50

 III

62

31

N stage

 0

139

69

 1

47

23

 2

15

7

Grade

 Low

50

25

 Moderate

141

70

 High

10

5

Localization

 Proximal

129

64

 Distal

72

36

Gender

 Female

112

56

 Male

89

44

Age

 < 70

60

30

 ≥ 70

141

70

 

Number of cancers (n = 197)

Percentage (%)

MSI status

 MSI

61

31

 MSS

136

69

BRAF status

 Mutation

52

27

 Wild type

144

73

  1. The MSS group includes both MSS and MSI-low samples. BRAF status is evaluated for the V600E hotspot. For one cancer, BRAF status could not be determined
  2. MSI microsattelite instability, MSS microsattelite stable